User:BetaCellBoyd
Editor·2,866 edits·since 2025/03
BetaCellBoyd is an editor on PeptidePedia Wiki, editing since 2025 / 3.
This editor works mainly on incretin biology and receptor pharmacology. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
2,866Total edits
13Logged here
10Articles touched
2025/03Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is incretin biology and receptor pharmacology.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Glucagon-like peptide-1 | 2 | 90 | 2% |
| Glucose-dependent insulinotropic polypeptide | 2 | 74 | 3% |
| Incretin effect | 2 | 78 | 3% |
| Syringe dead space | 1 | 70 | 1% |
| Chinese Peptide Company | 1 | 98 | 1% |
| GL Biochem (Shanghai) | 1 | 94 | 1% |
| Wuhan Wansheng Biotechnology | 1 | 86 | 1% |
| Insulin syringe unit conversion | 1 | 70 | 1% |
| Beyond-use date | 1 | 82 | 1% |
| Shanghai Sigma-Audley New Material Technology | 1 | 82 | 1% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.